Abstract
This chapter deals with the radiotherapy and cytotoxic chemotherapy of the malignant lympho-mas. Included within this group are Hodgkin’s disease, non-Hodgkin’s lymphoma, mycosis fun-goides, and chronic lymphatic leukaemia. A further section deals with the myeloproliferative disorders, including granulocytic leukaemia, polycythaemia vera, and primary thrombocy-thaemia. Excluded are myeloma and reticulum cell sarcoma of bone, which are dealt with in Chap. 15, and acute leukaemia, which is discussed in Chap. 16. With regard to Hodgkin’s disease, the past 25 years have seen general recognition of the curative potential of radiotherapy, at least in the local stages, and, more recently, awareness of the ability to achieve long-term survival after combination chemotherapy in generalised or in recurrent disease. At the same time the importance of staging has become appreciated and the introductionof procedures such as lymphography, staging laparotomy, and computer tomography (CT) has enormously increased its reliability. Advances have not been so dramatic in the complex group of non-Hodgkins’s lymphomas, but are still very real.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Recommended Further Reading
Crowther D (1979) Annual review: chemotherapy for lymphoma. In HM Pinedo (ed) Cancer chemotherapy annual
de Vita VT, Canellos GP, Chabner B, Schein P, Hubbard SP, Young RC (1975) Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet I: 248–250
de Vita VT, Lewis BJ, Rosencweig M, Muggia FM, (1978) The chemotherapy of Hodgkin’s disease. Past experience and future directions. Cancer 42: 979
Hainan KE, Russell MH (1965) Polycythaemia vera: comparison of survival and causes of death in patients managed with and without radiotherapy.Lancet II: 760
Irving M (1975) The role of surgery in the management of Hodgkin’s disease. Br J Surg 62: 853–862
Johnson RE (1972) Remission induction and remission duration with primary radiotherapy in advanced lymphosarcoma. Cancer 29: 1473
Kaplan HS (1980) Hodgkin’s disease. Harvard University Press, Cambridge, Mass.
Lutzner M, Edelson R, Schein P, Green I, Kirkpatrick C, Ahmed A (1975) Cutaneous T-cell lymphomas: the Sezary syndrome, mycosis fungoides and related disorders. Ann Intern Med 83: 534–552
Schein PS, Winokur SH (1975) Immunosuppres-sive and cytotoxic chemotherapy: long-term complications. Ann Intern Med 82: 84–95
Shalet SM (1980) Effects of chemotherapy on gonadal function of patients. Cancer Treatment Rev (1980) 7: 141–152
Smithers DW (1973) Hodgkin’s disease. Churchill Livingstone, Edinburgh London
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Todd, I.D.H. (1985). Malignant Lymphomas (including Myeloproliferative Disorders). In: Easson, E.C., Pointon, R.C.S. (eds) The Radiotherapy of Malignant Disease. Springer, London. https://doi.org/10.1007/978-1-4471-3322-3_14
Download citation
DOI: https://doi.org/10.1007/978-1-4471-3322-3_14
Publisher Name: Springer, London
Print ISBN: 978-1-4471-3324-7
Online ISBN: 978-1-4471-3322-3
eBook Packages: Springer Book Archive